Welcome to Clinuvel
- Clinuvel
- About Us
- News
- Our Products
- SCENESSE®
- CUV9900
- Our Expertise
- Science of Skin
- Mothers & Children
We are a global biopharmaceutical company committed to developing drugs for the treatment of a range of severe skin disorders.
Our website has been developed to help share our expertise on the interaction of light and human skin as well as provide a thorough overview of our global drug development programs.
Clinuvel Latest News
Updated: Clinuvel announces EU Phase III EPP resultsClinuvel has released results from its Phase III study of SCENESSE® (afamelanotide) in the... Read more |












